| 246.8 -3.93 (-1.57%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 304.24  |
1-year : | 322.51 |
| Resists | First : | 260.48 |
Second : | 276.13 |
| Pivot price | 255.9 |
|||
| Supports | First : | 235.16 |
Second : | 195.66 |
| MAs | MA(5) : | 252.68 |
MA(20) : | 258.94 |
| MA(100) : | 267.51 |
MA(250) : | 231.6  |
|
| MACD | MACD : | -3.7 |
Signal : | -3.1 |
| %K %D | K(14,3) : | 41.9 |
D(3) : | 45.3 |
| RSI | RSI(14): 42.5 |
|||
| 52-week | High : | 289.45 | Low : | 160.19 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PODD ] has closed above bottom band by 16.3%. Bollinger Bands are 9.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 249.22 - 250.58 | 250.58 - 251.71 |
| Low: | 231.96 - 233.61 | 233.61 - 234.98 |
| Close: | 244.21 - 246.83 | 246.83 - 249.01 |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Thu, 10 Apr 2025
Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength? - Nasdaq
Tue, 08 Apr 2025
PODD Stock Benefits From the Launch of Omnipod 5 in Canada - Nasdaq
Thu, 03 Apr 2025
Insulin Tech Leader Insulet Readies Q1 2025 Results: What's Next for Omnipod Maker? - Stock Titan
Thu, 03 Apr 2025
Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025 - Business Wire
Mon, 24 Mar 2025
Insulet Gains 62.9% in a Year: What's Driving the Stock? - Yahoo Finance
Tue, 18 Mar 2025
Insulet Announces Pricing of Senior Notes Due 2033 - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 70 (M) |
| Shares Float | 70 (M) |
| Held by Insiders | 0.3 (%) |
| Held by Institutions | 102.9 (%) |
| Shares Short | 2,880 (K) |
| Shares Short P.Month | 2,160 (K) |
| EPS | 5.76 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 17.26 |
| Profit Margin | 20.1 % |
| Operating Margin | 16 % |
| Return on Assets (ttm) | 6.8 % |
| Return on Equity (ttm) | 43 % |
| Qtrly Rev. Growth | 17.2 % |
| Gross Profit (p.s.) | 20.64 |
| Sales Per Share | 29.47 |
| EBITDA (p.s.) | 5.54 |
| Qtrly Earnings Growth | -6.2 % |
| Operating Cash Flow | 430 (M) |
| Levered Free Cash Flow | 155 (M) |
| PE Ratio | 42.77 |
| PEG Ratio | 0 |
| Price to Book value | 14.29 |
| Price to Sales | 8.37 |
| Price to Cash Flow | 40.28 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|